{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:11:57Z","timestamp":1767928317603,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jcyt.2012.11.012","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T07:40:48Z","timestamp":1362037248000},"page":"352-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells"],"prefix":"10.1016","volume":"15","author":[{"given":"Mehdi","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurtulus","family":"Buruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2012.11.012_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines","volume":"117","author":"Gilboa","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcyt.2012.11.012_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2796.2010.02317.x","article-title":"Dendritic cells and immunity against cancer","volume":"269","author":"Palucka","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib3","first-page":"299","article-title":"Dendritic cell based vaccines for immunotherapy of cancer","volume":"1","author":"Asim","year":"2003","journal-title":"Cancer Ther"},{"key":"10.1016\/j.jcyt.2012.11.012_bib4","first-page":"620","article-title":"Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy","volume":"31","author":"Hatfield","year":"2008","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2012.11.012_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00262-008-0638-7","article-title":"Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches","volume":"58","author":"Fry","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2012.11.012_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Ralph","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2012.11.012_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1634\/stemcells.21-4-495","article-title":"Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines","volume":"21","author":"Stefano","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2012.11.012_bib8","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/iai.65.8.3386-3390.1997","article-title":"Borrelia burgdorferi pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes","volume":"65","author":"Mbow","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcyt.2012.11.012_bib9","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/JVI.72.5.3812-3818.1998","article-title":"Dendritic cells efficiently induce protective antiviral immunity","volume":"72","author":"Ludewig","year":"1998","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/cimm.2000.1736","article-title":"A\u00a0mouse model for immunization with ex vivo virus-infected dendritic cells","volume":"206","author":"Lopez","year":"2000","journal-title":"Cellular Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-0378(00)00094-2","article-title":"Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection","volume":"50","author":"Sch\u00f6n","year":"2001","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib12","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A\u00a0dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Silvia","year":"2003","journal-title":"Blood J"},{"key":"10.1016\/j.jcyt.2012.11.012_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.188.5.809","article-title":"Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae","volume":"188","author":"Hua","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2008-0446OC","article-title":"Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen","volume":"41","author":"Ozawa","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-0556-2-17","article-title":"DNA vaccines: designing strategies against parasitic infections","volume":"2","author":"Catherine","year":"2004","journal-title":"Genet Vaccines and Ther"},{"key":"10.1016\/j.jcyt.2012.11.012_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.mt.6300333","article-title":"Vaccination against hepatitis C virus with dendritic cells transduced with adenovirus encoding NS3 protein","volume":"16","author":"Zabaleta","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2012.11.012_bib18","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/429340","article-title":"Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection","volume":"191","author":"Garc\u00eda","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2012.11.012_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jmv.20612","article-title":"Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial","volume":"78","author":"Ide","year":"2006","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with HIV-1 peptide-loaded dendritic cells is safe and immunogenic in HIV","volume":"15","author":"Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.510280332","article-title":"Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C","volume":"2","author":"Lasarte","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jcyt.2012.11.012_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcv.2004.03.006","article-title":"Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus","volume":"30","author":"Gowans","year":"2004","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2005.02919.x","article-title":"Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection","volume":"142","author":"Encke","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2007.01.001","article-title":"Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I: C) and anti-CD40","volume":"74","author":"Zabaleta","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcyt.2012.11.012_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2567.2003.01699.x","article-title":"Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape","volume":"109","author":"Beckebaum","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2012.11.012_bib26","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1099\/vir.0.80143-0","article-title":"Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection","volume":"85","author":"Tavakoli","year":"2004","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.hepres.2004.03.003","article-title":"Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers","volume":"29","author":"Akbar","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jcyt.2012.11.012_bib28","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3748\/wjg.v11.i12.1806","article-title":"Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study","volume":"11","author":"Chen","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0264-410X(89)90158-8","article-title":"Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents","volume":"7","author":"Erturk","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.jcyt.2012.11.012_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2249.2006.03281.x","article-title":"Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro","volume":"147","author":"Shi","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01309630","article-title":"Acute and latent infection of mice immunized with HSV-1 ISCOM vaccine","volume":"125","author":"Erturk","year":"1992","journal-title":"Arch Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jmv.1890310206","article-title":"Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents","volume":"31","author":"Jennings","year":"1990","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jcyt.2012.11.012_bib34","first-page":"19","article-title":"Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation","volume":"108","author":"Al-Ghamdi","year":"1989","journal-title":"ArchVirol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0197-4580(01)00239-1","article-title":"Vaccination prevents latent HSV1 infection of mouse brain","volume":"22","author":"Lin","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jcyt.2012.11.012_bib36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1099\/0022-1317-64-7-1491","article-title":"Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation","volume":"64","author":"Harbour","year":"1983","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib37","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1084\/jem.20021348","article-title":"Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control","volume":"198","author":"Mullins","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.coi.2005.01.004","article-title":"Migration of dendritic cell based cancer vaccines: in vivo veritas","volume":"17","author":"Gosse","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14653240410005258","article-title":"Current issues in delivering DCs for immunotherapy","volume":"6","author":"Barrat-Boyes","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2012.11.012_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0264-410X(01)00407-8","article-title":"Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein","volume":"20","author":"Moriya","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jcyt.2012.11.012_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2893.2008.00959.x","article-title":"Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity","volume":"15","author":"Yu","year":"2008","journal-title":"J\u00a0Viral Hepatol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib42","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1128\/JVI.77.12.6692-6699.2003","article-title":"Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice","volume":"77","author":"Richards","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib43","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2005.10.017","article-title":"Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2","volume":"24","author":"Quenelle","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jcyt.2012.11.012_bib44","first-page":"197","article-title":"Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB\/c mice","volume":"30","author":"Ghaemi","year":"2007","journal-title":"Microbiol Infect Dis"},{"key":"10.1016\/j.jcyt.2012.11.012_bib45","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/jid.2009.86","article-title":"Prevention of genital herpes simplex virus type 1and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1","volume":"129","author":"Brans","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib46","first-page":"321","article-title":"Herpes virus subunit vaccine: characterization of the virus strain used and testing of the vaccine","volume":"52","author":"Hilfenhaus","year":"1982","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.jcyt.2012.11.012_bib47","first-page":"333","article-title":"Passive immunoprotection by HSV specific monoclonal antibodies and monoclonal antibody resistant mutants altered in pathogenicity","volume":"7","author":"Kumel","year":"1985","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/infdis\/157.5.897","article-title":"Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent and latent genital infections with herpes simplex virus type 2 in guinea-pigs","volume":"157","author":"Berman","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2012.11.012_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.165.2.459","article-title":"A\u00a0synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2","volume":"165","author":"Watari","year":"1987","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib50","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.4049\/jimmunol.160.12.5998","article-title":"Role of mucosal immunity in herpes simplex virus infection","volume":"160","author":"Kuklin","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib51","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.4049\/jimmunol.160.12.6093","article-title":"T\u00a0lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2","volume":"160","author":"Milligan","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.jcyt.2012.11.012_bib52","first-page":"161A","article-title":"Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines","volume":"11","author":"Stanberry","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.jcyt.2012.11.012_bib53","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/315376","article-title":"Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs","volume":"181","author":"Simms","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2012.11.012_bib54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/icb.1996.84","article-title":"Masters of deception: a review of herpesvirus immune evasion strategies","volume":"74","author":"Davis-Poynter","year":"1996","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/mpat.1999.0314","article-title":"Either a CD4+ or CD8+T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice","volume":"27","author":"Ghiassi","year":"1999","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jcyt.2012.11.012_bib56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coi.2004.05.003","article-title":"Immune control of herpes simplex virus during latency","volume":"16","author":"Khanna","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib57","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1128\/JVI.01159-08","article-title":"Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords","volume":"82","author":"Johnson","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib58","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1084\/jem.20082039","article-title":"Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus","volume":"205","author":"Iijima","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2012.11.012_bib59","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.00551-08","article-title":"A\u00a0replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine","volume":"82","author":"Brittle","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2012.11.012_bib60","series-title":"Human herpesviruses: biology, therapy, and immunoprophylaxis","article-title":"Herpes simplex vaccines","author":"Arvin","year":"2007"},{"key":"10.1016\/j.jcyt.2012.11.012_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14728214.13.1.41","article-title":"The potential impact of a prophylactic herpes simplex vaccine","volume":"13","author":"Rupp","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jcyt.2012.11.012_bib62","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1172\/JCI57148","article-title":"HSV-2: in pursuit of a vaccine","volume":"121","author":"Johnston","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcyt.2012.11.012_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Robert","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:17:10Z","timestamp":1761430630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324912000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1465324912000412"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2012.11.012","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2012.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}